Kenji Utsumi
Asia-Pacific Guide 2024
Band 1 : Life Sciences
Email address
[email protected]Contact number
+81 3 6889 7154Share profile
Band 1
About
Provided by Kenji Utsumi
Practice Areas
Kenji Utsumi is a partner at Nagashima Ohno & Tsunematsu. He regularly counsels domestic and foreign clients on a variety of general corporate and other legal matters.
Mr. Utsumi has advised clients, as their main legal counsel, on large transactions, particularly real estate transactions and transactions in the life sciences industry, several of which have been nominated for special recognition as the "Deal of the Year in Japan" in their particular categories.
Mr. Utsumi also regularly represents domestic and foreign pharmaceutical companies, as their main legal counsel, on domestic and cross-border M&A and joint venture transactions, and provides advice on a variety of legal matters. Mr. Utsumi's expertise particularly encompasses pharmaceutical and life science regulations.
Mr. Utsumi regularly counsels a number of TSE and SGX listed REIT clients as well as non- listed private REITs and real estate private equity funds on a wide range of matters including asset acquisitions, formation, public offerings, M&A and restructuring of REITs and real estate private equity funds. Mr. Utsumi has substantial experience with respect to real estate private equity funds and has represented real estate fund managers, fund investors, lenders and tenants, and was informed that he is known as “the lawyer who has assisted his clients in acquiring the largest amount of real estates in Japan.”
In addition to his private practice, Mr. Utsumi teaches Civil Case Law at The University of Tokyo School of Law as an Visiting Professor of Law, and is a Japan Chapter Board Member of the Asia Pacific Real Assets Association (APREA).
Career
1992
The University of Tokyo (LL.B.)
1994-
Nagashima & Ohno (currently Nagashima Ohno & Tsunematsu)
1999
University of Pennsylvania Law School (LL.M.)
1999-2000
Paul, Hastings, Janofsky & Walker, Los Angeles
2003-present
Partner, Nagashima Ohno & Tsunematsu
2022 - present
Visitng Professor of Law, The University of Tokyo School of Law
2023-present
Japan Chapter Board Member, Asia Pacific Real Assets Association (APREA)
Publications
Chambers Global Practice Guides Life Sciences 2022 Japan – Law & Practice, published by Chambers (Co-author)
Medicinal product regulation and product liability in Japan: overview (2020), published by Practical Law - Thomson Reuters (Co-author)
Getting the Deal Through – Real Estate 2016 Japan, published by Law Business Research Ltd (Co-author)
Advanced New Companies Act, 3rd edition, published by Shojihomu (Co-author)
Lawyers’ contributions to real estate transactions, The Lawyers, May 2006
Overcoming the risks of choosing real estate for investment trusts - The IFLR Guide to Japan 2004, published by Euromoney Institutional Investor PLC (Co-author)
The development of Japanese real estate investment trusts - The IFLR Guide to Japan 2003, published by Euromoney Institutional Investor PLC (Co-author)
The Business Judgment Rule and Shareholder Derivative Suits in Japan, published by New York International Law Review
Introduction to the US Real Estate Transactions - Journal of The Japanese Institute of International Business Law, Vol.28 No.11
Chambers Review
Asia-Pacific
Kenji Utsumi is a legendary figure in the team and also in the wider life sciences industry. He advises leading Japanese and foreign pharmaceutical companies on a full range of business integration, regulatory and litigation work.
Contributions
Latest contributions provided by Kenji Utsumi
Strengths
Provided by Chambers
"We are grateful for his accurate advice that is in line with the content of the business and based on a thorough understanding of the relevant laws and regulations."
"We are grateful for his accurate advice that is in line with the content of the business and based on a thorough understanding of the relevant laws and regulations."